Article Information
History
- May 5, 2020.
Article Versions
- Version 1 (April 30, 2020 - 17:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- B Korber1,*,
- WM Fischer1,
- S Gnanakaran1,
- H Yoon1,
- J Theiler1,
- W Abfalterer1,
- B Foley1,
- EE Giorgi1,
- T Bhattacharya1,
- MD Parker3,
- DG Partridge4,
- CM Evans4,
- TM Freeman3,
- TI de Silva4,5,
- on behalf of the Sheffield COVID-19 Genomics Group#,
- CC LaBranche2 and
- DC Montefiori2
- 1T6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545 USA
- 2Duke Human Vaccine Institute & Department of Surgery, Durham, North Carolina, 27710 USA
- 3Sheffield Biomedical Research Centre & Sheffield Bioinformatics Core, University of Sheffield, Sheffield, UK
- 4Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
- 5Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK
- ↵*Corresponding Author and Lead Contact: Bette Korber, btk{at}lanl.gov
Declaration of Interests: The authors declare no competing interests.